Skip to content

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

Rafael G. Dos Santos, Fermanda M Balthazar, José Carlos Bouso, Jaime Ec Hallak

Journal of Psychopharmacology June 11, 2016 DOI: 10.1177/0269881116652578 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Topics Ayahuasca Default mode network
Keywords Hallucinogen Mood Impulsivity Neuropsychology Clinical psychology Neuroimaging Cognition Psychopathology Anterior cingulate cortex Bipolar disorder
Citations 126
Key findings Acute, subacute, and long-term ayahuasca use appears to have low toxicity and is associated with positive mood, cognitive improvements, and reduced impulsivity without increased psychopathology.

Abstract

Rationale: In recent decades, the use of ayahuasca (AYA) – a β-carboline- and dimethyltryptamine-rich hallucinogenic botanical preparation traditionally used by Northwestern Amazonian tribes for ritual and therapeutic purposes – has spread from South America to Europe and the USA, raising concerns about its possible toxicity and hopes of its therapeutic potential. Thus, it is important to analyze the acute, subacute, and long-term effects of AYA to assess its safety and toxicity.

Objectives: The purpose of this study was to conduct a systematic review of human studies assessing AYA effects on psychiatric symptoms, neuropsychological functioning, and neuroimaging.

Methods: Papers published until 16 December 2015 were included from PubMed, LILACS and SciELO databases following a comprehensive search strategy and pre-determined set of criteria for article selection.

Results: The review included 28 full-text articles. Acute AYA administration was well tolerated, increased introspection and positive mood, altered visual perceptions, activated frontal and paralimbic regions and decreased default mode network activity. It also improved planning and inhibitory control and impaired working memory, and showed antidepressive and antiaddictive potentials. Long-term AYA use was associated with increased cortical thickness of the anterior cingulate cortex and cortical thinning of the posterior cingulate cortex, which was inversely correlated to age of onset, intensity of prior AYA use, and spirituality. Subacute and long-term AYA use was not associated with increased psychopathology or cognitive deficits, being associated with enhanced mood and cognition, increased spirituality, and reduced impulsivity.

Conclusions: Acute, subacute, and long-term AYA use seems to have low toxicity. Preliminary studies about potential therapeutic effects of AYA need replication due to their methodological limitations.

Comparable studies

Other systematic reviews and meta-analyses on ayahuasca, most cited first.

Study Year Design Participants
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Humans (ritual ayahuasca use) 2006 Systematic review
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies 2017 Systematic review
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Participants in studies of psychedelic therapy for depressive symptoms (Major... 2023 Systematic review with meta-analysis n = 14

Citations in the library

Cited by 108

and 103 more in the library

Cites 90

and 85 more in the library

Explore topics